Trevi Therapeutics
Clinical trials sponsored by Trevi Therapeutics, explained in plain language.
-
Could a painkiller improve breathing in lung fibrosis patients?
Symptom relief Recruiting nowThis early-stage study is testing an extended-release tablet called nalbuphine ER in 10 people with idiopathic pulmonary fibrosis (IPF). The main goal is to see if the drug is safe and whether it affects breathing function. Researchers will monitor oxygen levels, breathing rate, …
Phase: PHASE1 • Sponsor: Trevi Therapeutics • Aim: Symptom relief
Last updated Jun 27, 2026 12:05 UTC
-
Does breakfast change how this pain drug works? new study investigates
Knowledge-focused Recruiting nowThis early-stage trial is testing whether eating a high-fat, high-calorie meal changes how the body absorbs nalbuphine extended-release tablets. Sixty healthy volunteers will take the drug once with food and once without, and researchers will compare drug levels in their blood. T…
Phase: PHASE1 • Sponsor: Trevi Therapeutics • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:00 UTC